Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Myrtle Beach
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Myrtle Beach, SC

Studies commonly pay $75 to $4,500 per completed study

89 clinical trials are currently recruiting participants within 30 miles of Myrtle Beach. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

89studies recruiting
6+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Myrtle Beach right now

Top 25 of 89 recruiting studies, sorted by proximity — each links to its official registry page

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Steba Biotech S.A.
See eligibility & contact on ClinicalTrials.gov (NCT04620239)

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase 1 Interventional 1,394 participants sought
Exelixis Clinical Site #9 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Exelixis
See eligibility & contact on ClinicalTrials.gov (NCT05176483)

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-sensitive Prostate Cancer Phase 2 Interventional 150 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06991556)

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Prostate Cancer Phase 3 Interventional 700 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06952803)

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer Phase 3 Interventional 750 participants sought
South Texas Accelerated Research Therapeutics - Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07213674)

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Non-muscle-invasive Bladder Cancer, NMIBC Phase 1 Interventional 55 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Aura Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT05483868)

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Prostate Cancer Phase 1, Phase 2 Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07336446)

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Metastatic Castration-resistant Prostate Cancer Phase 3 Interventional 670 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07611110)

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 641 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06319820)

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Alopecia Areata Phase 3 Interventional 1,330 participants sought
Alliance for Multispecialty Research, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06873945)

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

High-risk Muscle Invasive Urothelial Carcinoma Phase 3 Interventional 915 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07720284)

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Urinary Bladder Neoplasms, Neoplasm Metastasis Phase 1 Interventional 677 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT05614739)

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma Phase 1, Phase 2 Interventional 91 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07123454)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Phase 1 Interventional 60 participants sought
South Texas Accelerated Research Therapeutics - Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07140900)

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought
Channel Research — Pawleys Island, South Carolina (23.5 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT01719055)

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 1, Phase 2 Interventional 350 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: enGene, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04752722)

A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

Pneumococcal Disease Phase 3 Interventional 4,670 participants sought
TMA Headlands LLC (d/b/a Trial Management Associates) — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07794748)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Bladder Carcinoma, Ureter Carcinoma N/A Observational 2,020 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Guardant Health, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05059444)

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients Phase 1 Interventional 144 participants sought
Carolina Urologic Research Center, the START Center for Cancer Research — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: K36 Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07103018)

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer Phase 2 Interventional 131 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Protara Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT05951179)

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Phase 2 Interventional 90 participants sought
Site 02-006 - Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Theralase® Technologies Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03945162)

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Insomnia Disorder Phase 3 Interventional 420 participants sought
Vanda Investigational Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Vanda Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06953869)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07028853)

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Non-muscle Invasive Bladder Cancer Phase 1 Interventional 294 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07206225)
Actively enrolling

Studies you may be able to join near Myrtle Beach

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Myrtle Beach

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

START Carolinas

★ 4.7
823 82nd Pkwy suite b, Myrtle Beach, SC 29572
(843) 839-1679
"Initial conference for stone removal. Didn’t learn anything I hadn’t already learned from the internet. In a holding pattern for surgery scheduling."
— Happy Jack, 4★

Advanced Clinical Trials

★ 5.0
291 SC-90 #291e, Little River, SC 29566
(843) 249-4129

Body Revolution Aesthetics & Wellness

★ 5.0
1211 48th Ave N, Myrtle Beach, SC 29577
(843) 213-1633

Coastal Carolina Research Center

★ 4.4
4920 O'Hear Ave Ste 101, North Charleston, SC 29405
(843) 856-3784
"I feel Coastal Carolina is a valuable asset to the research community in the Charleston area. They are extremely welcoming and professional. Their ex…"
— Pam, 5★

Little River Medical Center

★ 4.4
4220 Carolina Exchange Dr, Myrtle Beach, SC 29579
(843) 663-8000
"Dr. Insignares is a great face for LRMC. With him, it is all about the patient—like it used to be!"
— ElizabethT, 5★

Clinical Research Center Of The Carolinas

1364 Ashley River Rd, Charleston, SC 29407
(843) 375-8111

Clinical trials in Myrtle Beach: what's recruiting

The Myrtle Beach area currently has 89 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Myrtle Beach, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney3 studies

Every listing shows the study phase, the recruiting site and its distance from Myrtle Beach, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Myrtle Beach

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Myrtle Beach participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Myrtle Beach pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Myrtle Beach, SC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Myrtle Beach?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Myrtle Beach typically complete one or two studies per year.

Paid clinical trials near Myrtle Beach

Other metros within reach

Wilmington, NC114 Fayetteville, NC124 Charleston, SC738 Columbia, SC191 Cary, NC1,688 Raleigh, NC1,680 Durham, NC1,688 Concord, NC644

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Myrtle Beach Bladder Issues Due To Spinal Cord Injury in Myrtle Beach All conditions

More of SC

Charleston738 Rock Hill603 Greenville377 Mauldin375 Spartanburg362 Columbia191

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts